Why Pharmacy Workers at CVS and Walgreens Are Protestingnews2023-11-01T10:17:07+00:00November 1st, 2023|The New York Times|
Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patientsnews2023-10-31T21:21:11+00:00October 31st, 2023|The New York Times|
F.D.A. Experts Will Vote on Safety of a Cure for Sickle Cell Diseasenews2023-10-30T20:19:43+00:00October 30th, 2023|The New York Times|
A New Sickle Cell Treatment Will Change Lives — but How Many?news2023-10-30T09:01:12+00:00October 30th, 2023|The New York Times|
Eyedrops From Major Brands May Cause Infection, F.D.A. Saysnews2023-10-29T23:47:48+00:00October 29th, 2023|The New York Times|
Los medicamentos cotra la obesidad tienen sobreprecio, pero esto puede cambiarnews2023-10-26T09:02:55+00:00October 26th, 2023|The New York Times|
R.S.V. Shot for Infants Is in Short Supply: What to Knownews2023-10-25T02:29:27+00:00October 25th, 2023|The New York Times|
Psychedelic Mushrooms Hit the Market in Oregonnews2023-10-23T09:01:31+00:00October 23rd, 2023|The New York Times|
How Much Do Ozempic and Wegovy Cost? Not What You Think.news2023-10-22T07:00:20+00:00October 22nd, 2023|The New York Times|
10 Charged in $20 Million Scheme to Sell Black-Market H.I.V. Drugsnews2023-10-21T02:05:57+00:00October 21st, 2023|The New York Times|
